Liver transplantation for propionic acidemia in children
Open Access
- 25 January 2011
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 17 (6), 661-667
- https://doi.org/10.1002/lt.22279
Abstract
Propionic acidemia (PA) is a rare inherited disorder of branched chain amino acid metabolism; despite improvements in conventional medical management, the long‐term outcome remains disappointing. Liver transplantation (LT) has been proposed to minimize the risk of further metabolic decompensations and to improve the quality of life. We performed a retrospective review of all children with PA who underwent LT between 1987 and 2008. Five children were identified with a median age of 1.2 years (range = 0.7‐4.1 years) at referral. Four of the children presented clinically at 3 weeks of age or less, and 1 child was diagnosed prenatally. All had metabolic acidosis and hyperammonemia. Two had seizures and required intensive care; this care included inotropic support and continuous venovenous hemofiltration in 1 child. The children were considered for elective LT for the following reasons: frequent metabolic decompensations (2), previous sibling death (2), and elective management (1). One child underwent auxiliary LT, and 4 children received orthotopic grafts (1 living related graft). The median age at LT was 1.5 years (range = 0.8‐7.0 years). There was 1 retransplant 3 months after LT due to hepatic artery thrombosis. One year after LT, 1 patient suffered a metabolic stroke with minimal residual neurology. After a median follow‐up of 7.3 years (range = 2.2‐15.0 years), all the children had normal graft function and a good quality of life with a protein‐unrestricted diet and no further metabolic decompensations. In conclusion, LT has a role in the management of PA: it reduces the risk of metabolic decompensation and improves the quality of life. The potential for the development of metabolic sequelae is not completely eliminated. Liver Transpl 17:661‐667, 2011. © 2011 AASLD.Keywords
This publication has 31 references indexed in Scilit:
- Auxiliary Liver Transplantation for Propionic Acidemia: A 10‐Year Follow‐UpAmerican Journal of Transplantation, 2007
- Evaluation and management of patients with propionic acidemia undergoing liver transplantation: A comprehensive reviewPediatric Transplantation, 2006
- Hepatocyte transplantation for liver‐based metabolic disordersJournal of Inherited Metabolic Disease, 2006
- Methylmalonic and propionic acidurias: Management without or with a few supplements of specific amino acid mixtureJournal of Inherited Metabolic Disease, 2006
- Methylmalonic and propionic acidaemias: Management and outcomeJournal of Inherited Metabolic Disease, 2005
- Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantationLiver Transplantation, 2005
- The impact of screening for propionic and methylmalonic acidaemiaEuropean Journal of Pediatrics, 2003
- Clinical outcome and long-term management of 17 patients with propionic acidaemiaEuropean Journal of Pediatrics, 1996
- Cardiomyopathy in propionic acidaemiaEuropean Journal of Pediatrics, 1993
- Neurologic outcome of propionic acidemiaPediatric Neurology, 1992